Pachyonychia congenita project: A partnership of patient and medical professional

Journal of the Dermatology Nurses' Association

Volumn 5, Issue 1, 2013, Pages 42-47

  Schwartz, Mary E ^a   Zimmerman, Gail M ^a   Smith, Frances ^b   Sprecher, Eli ^c,d  

^a Pachyonychia Congenita Project   (United States)

^b UNIVERSITY OF DUNDEE   (United Kingdom)

^c TEL AVIV SOURASKY MEDICAL CENTER   (Israel)

^d TEL AVIV UNIVERSITY   (Israel)

Author keywords

Blisters; Cysts; Keratoderma; Nail dystrophy

Indexed keywords

RETINOID;

ARTICLE; AWARENESS; CLINICAL FEATURE; CONGENITAL PACHYONYCHIA; DOCTOR PATIENT RELATION; DRUG SAFETY; GENETIC ASSOCIATION; HUMAN; INTEGRATED HEALTH CARE SYSTEM; MANAGED CARE; MEDICAL SPECIALIST; MOLECULAR PATHOLOGY; NURSE PATIENT RELATIONSHIP; NURSING ROLE; PAIN; PATIENT INFORMATION; PRIORITY JOURNAL; RARE DISEASE; RISK BENEFIT ANALYSIS; SKIN EXAMINATION; SYMPTOM ASSESSMENT;

EID: 84878033608     PISSN: 1945760X     EISSN: None     Source Type: Journal    
DOI: 10.1097/JDN.0b013e31827d9ed5     Document Type: Article

References (11)

1. Akasaka, E., Nakano, H., Nakano, A., Toyomaki, Y., Takiyoshi, N., Rokunohe, D., & Sawamura, D. (2011). Diffuse and focal palmoplantar keratoderma can be caused by a keratin 6c mutation. British Journal of Dermatology, 165(6), 1290-1292. doi: 10.1111/j.1365-2133.2011.10552.x.
2. Eliason, M. J., Leachman, S. A., Feng, B. J., Schwartz, M. E., & Hansen, C. D. (2012). A review of the clinical phenotype of 254 patients with genetically confirmed pachyonychia congenita. Journal of the American Academy of Dermatology, 67, 680-686. doi: 10.1016/j.jaad.2011.12.009.
3. Gonzalez-Gonzalez, E., Speaker, T. J., Hickerson, R. P., Spitler, R., Flores, M. A., Leake, D., & Kaspar, R. L. (2010). Silencing of reporter gene expression in skin using siRNAs and expression of plasmid DNA delivered by a soluble protrusion array device (PAD). Molecular Therapy, 18(9), 1667-1674. doi: 10.1038/mt.2010.126.
4. Gruber, R., Edlinger, M., Kaspar, R. L., Hansen, C. D., Leachman, S., Milstone, L. M., & Schmuth, M. (2011). An appraisal of oral retinoids in the treatment of pachyonychia congenita. Journal of the American Academy ofDermatology, 66, e193-199. doi: 10.1016/j.jaad.2011.02.003.
5. Hickerson, R. P., Flores, M. A., Leake, D., Lara, M. F., Contag, C. H., Leachman, S. A., & Kaspar, R. L. (2011). Use of self-delivery siRNAs to inhibit gene expression in an organotypic pachyonychia congenita model. Journal of Investigative Dermatology, 131(5), 1037-1044. doi:10.1038/jid.2010.426.
6. Irvine, A. D. (2012). Double trouble: Homozygous dominant mutations and hair loss in pachyonychia congenita. Journal of Investigative Dermatology, 132(7), 1757-1759. doi: 10.1038/jid.2012.121.
7. Jadassohn, J. L. F. (1906). Pachyonychia congenita: Keratosis disseminata circumscripta (follicularis). In Tylomata. Lukokeratosis linguage (Vol. 1, p. 29). Berlin, Germany: Urban and Schwarzenberg.
8. Leachman, S. A., Hickerson, R. P., Schwartz, M. E., Bullough, E. E., Hutcherson, S. L., Boucher, K. M., & Kaspar, R. L. (2010). First-inhuman mutation-targeted siRNA phase 1b trial of an inherited skin disorder. Molecular Therapy, 18(2), 442-446. doi: 10.1038/mt.2009.273.
9. McLean, W. H., Hansen, C. D., Eliason, M. J., & Smith, F. J. (2011). The phenotypic and molecular genetic features of pachyonychia congenita. Journal of Investigative Dermatology, 131(5), 1015-1017. doi: 10.1038/jid.2011.59.
10. Wilson, N. J., Leachman, S. A., Hansen, C. D., McMullan, A. C., Milstone, L. M., Schwartz, M. E., & Smith, F. J. (2011). A large mutational study in pachyonychia congenita. Journal of Investigative Dermatology, 131(5), 1018-1024. doi: 10.1038/jid.2011.20.
11. Wilson, N. J., Messenger, A. G., Leachman, S. A., O'Toole, E. A., Lane, E. B., McLean, W. H., & Smith, F. J. (2010). Keratin K6c mutations cause focal palmoplantar keratoderma. Journal of Investigative Dermatology, 130(2), 425-429. doi: 10.1038/jid.2009.215.